Medicinal inorganic chemistry: an updated review on the status of metallodrugs and prominent metallodrug candidates

Author:

Miranda Victor M.1ORCID

Affiliation:

1. Instituto de Química de São Carlos, Universidade de São Paulo , São Carlos , SP , Brazil

Abstract

Abstract Metallodrugs correspond to a small portion of all available drugs in the market and, yet, some of them are among the most used and important drugs in modern medicine. However, medicinal inorganic chemistry remains an underestimated area within medicinal chemistry and the main reason is the mislead association of metals to toxic agents. Thus, in this review, the potential of medicinal inorganic chemistry in drug designing is highlighted through a description of the current status of metallodrugs and metallodrug candidates in advanced clinical trials. The broad spectrum of application of metal-based drugs in medicine for both therapy and diagnosis is addressed by the extensive list of examples presented herein.

Publisher

Walter de Gruyter GmbH

Subject

Inorganic Chemistry

Reference198 articles.

1. Abuchowski, A. SANGUINATE (PEGylated carboxyhemoglobin bovine): mechanism of action and clinical update. Artif. Organs2017, 41, 346–350. https://doi.org/10.1111/aor.12934.

2. Accelerated Pharma. Form S-1 2016, 2016. https://www.sec.gov/Archives/edgar/data/1630970/000114420416130880/v451545_s1a.htm (accessed Jun 10, 2020).

3. Accelerated Pharma. Picoplatin, 2020. http://apipharmaceuticals.com/planned_trials.html (accessed Jun 10, 2020).

4. Actinium Pharmaceuticals. Venetoclax and Lintuzumab-Ac225 in AML patients, 2019. https://clinicaltrials.gov/ct2/show/NCT03867682 (accessed Oct 19, 2020).

5. Adgero Biopharmaceuticals, Inc.REM-001 therapy, 2020. https://www.adgerobiopharm.com/product-pipeline/rem-001-therapy (accessed May 22, 2020).

Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3